RE:RE:RE:RE:Jazz Pharmaceutical BUYOUT.Wednesday LABS may submit a patent challenge to the FDA on Epidiolex...the review may take upto 180 days from filing...if successful, LABS, using the DEL and the now active FDA masterfile can ship it's CBD 100 formulation under a new name as a generic for Epidiolex...this is the only FDA approved cannabinoid based pharmaceutical in the U.S and is Pure CBD oil taken as such with a price of 1700-2200$ for a 100ml bottle....covered by insurers....... management commentary has stated multiple times they plan on "challenging patents for FDA approved cannabinoid drugs" ...they've taken all necessary steps and obtained all necessary certs for this to happen. This challenge is the last step for this generic offering to become reality....no other company is position for this...I'm expecting a P/R Wednesday or shortly after officially acknowledging the now active FDA masterfile along with the submitted FDA patent challenge for Epidiolex....